Vaccinex financials at a glance

+ Portfolio

The revenue of Vaccinex is reported as 0.00063 billion Dollars in the fiscal year 2023. The earnings were -323.4 Dollars per share in 2023, which was 1300 lower than 2020. And about -7.0E-5 billion Dollars are reported as free cash flow in the financials of Vaccinex 2023. No dividends were paid to the shareholders of the Vaccinex stock NasdaqCM:VCNX in the financial year 2023.

$0.63M

Revenue

$-,323.40

Earnings Per Share

0.00%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

0.63

Earnings Per Share

-,323.40

Gross Margin %

0.00

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2020	2019	2018
Rev.	Revenue	N/A	$0.63M	$0.63M	$0.52M	$0.72M
GM %	Gross Margin %	0.00%	0.00%	0.00%	0.00%	-42.68%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-5.94	$-,323.40	$-23.10	$-37.05	$-84.75
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0
Sha.	Shares	N/AM	1.23M	1.9M	1.09M	0.77M
OCF	Operating Cash Flow	N/A	$0.00M	$0.00M	$0.00M	$0.00M
FCF	Free Cash Flow	N/A	$0.00M	$0.00M	$0.00M	$0.00M
FCFS	Free Cash Flow Per Share	$-4.91	$-37.31	$-1.54	$-2.39	$-4.88

Vaccinex financials at a glance

Financials

Discover